1.
Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines
by Sipe, Jean D.
Amyloid, 2016-10-01, Vol.23 (4), p.209-213
2.
CSP-1103 (CHF5074) stabilizes human transthyretin in healthy human subjects
by Qiang, Lixia
Amyloid, 2017-01-02, Vol.24 (1), p.42-51
3.
Hereditary ATTR amyloidosis: a single-institution experience with 266 patients
by Swiecicki, Paul L
Amyloid, 2015-06, Vol.22 (2), p.123-131
4.
Oligomeric TTR V30M aggregates compromise cell viability, erythropoietin gene expression and promoter activity in the human hepatoma cell line Hep3B
by Moreira, Luciana
Amyloid, 2015-06, Vol.22 (2), p.93-99
5.
Most recent common ancestor of TTR Val30Met mutation in Italian population and its potential role in genotype-phenotype correlation
by Iorio, Andrea
Amyloid, 2015-06, Vol.22 (2), p.73-78
6.
Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy
by Benson, Merrill D.
Amyloid, 2017-10-02, Vol.24 (4), p.217-223
7.
Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial
by Waddington-Cruz, Marcia
Amyloid, 2018-07-03, Vol.25 (3), p.180-188
8.
Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis
by Butler, James S.
Amyloid, 2016-04-02, Vol.23 (2), p.109-118
9.
Pseudo-homozygous mutation due to a primer site polymorphism in hereditary ATTR amyloidosis: a pitfall of PCR-based genetic testing
by Shibata, Yuka
Amyloid, 2017-01-02, Vol.24 (1), p.66-67
10.
Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases
by Beirão, João Melo
Amyloid, 2015-06, Vol.22 (2), p.117-122
11.
A novel transthyretin variant V28S (p.V48S) with a double-nucleotide substitution in the same codon
by Okada, Masamitsu
Amyloid, 2017-10-02, Vol.24 (4), p.248-249
12.
Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR)
by Phull, Pooja
Amyloid, 2018-01-02, Vol.25 (1), p.62-67
13.
Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis
by Brown, Emily E.
Amyloid, 2017-04-03, Vol.24 (2), p.92-95
14.
Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population
by Hellman, Urban
Amyloid, 2008, Vol.15 (3), p.181-186
15.
Frequency of the transthyretin Val30Met mutation in the northern Swedish population
by Olsson, Malin
Amyloid, 2014-03, Vol.21 (1), p.18-20
16.
Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy
by Ackermann, Elizabeth J
Amyloid, 2012-06, Vol.19 (S1), p.43-44
17.
Misidentification of transthyretin and immunoglobulin variants by proteomics due to methyl lysine formation in formalin-fixed paraffin-embedded amyloid tissue
by Canetti, Diana
Amyloid, 2017-10-02, Vol.24 (4), p.229-237
18.
Islet amyloid with macrophage migration correlates with augmented β-cell deficits in type 2 diabetic patients
by Kamata, Kosuke
Amyloid, 2014-09, Vol.21 (3), p.191-201
19.
Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center's experience
by Ikram, Asad
Amyloid, 2018-07-03, Vol.25 (3), p.197-202
20.
Transthyretin amyloidosis: a phenocopy of hypertrophic cardiomyopathy
by Vermeer, Alexa M. C.
Amyloid, 2017-04-03, Vol.24 (2), p.87-91
Filter electronic articles 326 Hits
Remove Filters
- Journal Title
- Amyloid
- Subjects
- Research & Experimental Medicine
- Science & Technology (326)
- Biochemistry & Molecular Bio... (326)
- more ...